Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patient Navigation × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18 Breast 10 Thoracic 9 Gynecologic 6 Tumor-Agnostic 4 Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 2 Plasma cell 1 Other solid neoplasm 1 Other 1 Head & Neck 1 Endocrine 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Dexamethasone 719 Lenalidomide 382 Bortezomib 381 Cyclophosphamide 310 Melphalan 236 Calcium Dobesilate 216 daratumumab 195 pomalidomide 166 carfilzomib 145 fludarabine 113 Thalidomide 107 fludarabine phosphate 104 Filgrastim 98 Peripheral Blood Stem Cell Transplantation 97 ixazomib 80 Whole-Body Irradiation 73 Granulocyte Colony-Stimulating Factor 73 dexamethasone acetate 72 Mycophenolic Acid 69 Busulfan 68 dexamethasone 21-phosphate 61 Tacrolimus 60 auricularum 56 Prednisone 56 Cyclosporine 54 isatuximab 53 belantamab mafodotin 51 elotuzumab 48 Antilymphocyte Serum 47 Etoposide 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡